Tag : genomic testing

Genomics

Bluestar Genomics to Participate in the Goldman Sachs 2022 Conference

Business Wire
Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation liquid biopsy approaches initially focused on non-invasive detection of high-mortality...
Genomics

LetsGetChecked to Acquire Veritas Genetics & Veritas Intercontinental

Business Wire
Leading healthcare solutions company adds whole genome sequencing to its at-home diagnostics and virtual care offering, enabling actionable genetic insights to guide a personalized customer...
Genomics

Thermo Fisher Scientific Launches CE-IVD Sequencing Instrument

Business Wire
Ion Torrent Genexus Dx Integrated Sequencer enables rapid NGS for diagnostic applications and clinical research Thermo Fisher Scientific today launched the CE-IVD marked Ion Torrent Genexus...
Genomics

Fortis Life Sciences Partners With AccuGenomics

Business Wire
Fortis Life Sciences, astrategic platform company providing capital, expertise, and operational resources to grow founder-led life science companies, today announced it is the exclusive channel...
Genomics

Catalytic Data Science Joins Integrated DNA Technologies Align Program

Business Wire
Partners in science unite to deliver cutting-edge next generation sequencing solutions (NGS) to researchers Global genomics solutions provider Integrated DNA Technologies (IDT) welcomes Catalytic Data Science to its Align...
Genomics

Online Course Addresses Gap in Education for Nongenetics Providers

PR Newswire
The unprecedented, rapid advances in genetic and genomic knowledge and technologies have made it challenging for primary care and other nongenetics healthcare providers to stay...
Genomics

Karin Eastham to Chair Personalis Board of Directors

Business Wire
Personalis’ oncology diagnostics business expected to build on foundation of advanced technology already the driver of rapidly growing revenue from pharmaceutical companies Personalis, Inc. (Nasdaq:...
Genomics

David Dimmock, M.D., Joins Creyon Bio as Chief Medical Officer

PR Newswire
Creyon Bio, Inc. (“Creyon Bio”), a drug development company engineering RNA-based medicines and their components (oligonucleotide-based medicines or OBMs) with predictable safety and efficacy profiles,...